News

23 June 16

Daniel Alain Life Science acquires intellectual property rights from Applied Biology

Daniel Alain Life Science to license revolutionary hair loss products. Newport Beach, CA (August 1, 2016) ¬ Daniel Alain Life Science, a new biotech company under The House of Daniel Alain, announced today that it has acquired the intellectual property rights for a revolutionary patented technology that reduces that amount of hair that is shed during washing and styling procedures....

Read More

21 June 16

Minoxidil dose response study in female pattern hair loss patients’ non-responders to 5%

Topical minoxidil is the only US FDA approve drug for the treatment of female pattern hair loss. The maximum strength of the legally marketed topical minoxidil in the US (5% minoxidil topical foam) is effective in regrowing hair in only a minority of women i.e., approximately 30%; thus, the majority of female pattern hair loss patients remain untreated. Previously, we...

Read More